Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Emisphere Technologies, Inc.

https://emisphere.com/

Latest From Emisphere Technologies, Inc.

Swiss Firm Amazentis' Supplement With Urolithin A For Age-Related Muscle Decline Debuts In US

Nestle-backed Amazentis says clinical studies show its Timeline Cellular Nutrition delivers “significant” improvement in muscle strength after four months and delivers six times more urolithin A than pomegranate juice. Direct-to-consumer sales currently are available only in the US.

Ingredients Launches

Nestle Prioritizes Affordable Nutrition As COVID-19 Threatens Lower-Income Consumers' Food Supply

Swiss confections, food and nutritional products giant launches Nestlé Cerevita Instant Sour Porridge as affordable nutrition for consumers in Southeast Africa. With micronutrients often lacking in consumers’ diets there, it was developed in about one year by scientists at Nestlé's R&D center in Côte d'Ivoire.

Dietary Supplements Commercial

Gilead Gets Option To Tizona's Novel HLA-G Checkpoint, Further Bulking Up Immune Checkpoint Arsenal

The big biotech will pay $300m to acquire a 49.9% equity interest in the cancer immunotherapy startup with a buyout option. It is one of several immune checkpoints Gilead has secured access to this year.

Deals ImmunoOncology

Coronavirus Update: Vaccine Companies To Update Lawmakers As Crisis Deepens In US

Executives from Moderna, Pfizer and AstraZeneca and others will give politicians in Washington DC an update on the progress of their vaccine - but will resist pressure to make promises of a breakthrough in 2020.

Coronavirus COVID-19 Policy
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Large Molecule
  • Other Names / Subsidiaries
    • Clinical Technologies Associates, Inc.
UsernamePublicRestriction

Register